Turner Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,000
Closed -$229K 74
2017
Q3
$229K Sell
3,000
-3,700
-55% -$280K 1.04% 44
2017
Q2
$503K Sell
6,700
-4,300
-39% -$298K 0.33% 92
2017
Q1
$718K Sell
11,000
-20,000
-65% -$1.18M 0.47% 80
2016
Q4
$1.71M Sell
31,000
-19,000
-38% -$1.04M 0.69% 48
2016
Q3
$2.83M Buy
50,000
+47,500
+1,900% +$2.33M 0.93% 35
2016
Q2
$104K Hold
2,500
0.03% 188
2016
Q1
$107K Sell
2,500
-18,500
-88% -$782K 0.03% 196
2015
Q4
$951K Sell
21,000
-28,920
-58% -$1.22M 0.2% 143
2015
Q3
$1.94M Sell
49,920
-31,880
-39% -$1.28M 0.39% 88
2015
Q2
$2.97M Buy
+81,800
New +$2.59M 0.54% 60

Other funds holding PRAH

Turner Investments's PRAH Position: Q4 2017 in Review

Turner Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 3,000 shares — an estimated $229K sold.

Turner Investments first reported a position in PRAH in Q2 2015 and held it in 10 quarters. The position peaked at $2.97M in Q2 2015. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Turner Investments reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Turner Investments sold 3,000 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $229K.
  • Turner Investments first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 10 quarters.
  • Turner Investments's PRA Health Sciences, Inc. position peaked at $2.97M in Q2 2015.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Turner Investments's 13F filing for Q4 2017, filed 2 Feb 2018.